Laboratory Corporation of America Holdings v. Qiagen Sciences, LLC, Appeal No. 2023-2350 (Fed. Cir. Aug. 13, 2025) – In our…
Read More →
The use of diffusion tensor imaging (“DTI”) to assess mild Traumatic Brain Injury (mTBI) has been discussed in several prior…
Read More →
361 IT and cybersecurity leaders reveal the ransomware realities for retail businesses today.…
Read More →
On August 13, 2025, President Trump signed an executive order aimed at strengthening America’s pharmaceutical supply chains. Officially titled “Ensuring…
Read More →
On July 31, 2025, the United States Department of Justice (DOJ) announced a $9.8 million settlement with Illumina, Inc. (Illumina)…
Read More →
Abstract – This article examines the problem of fabricated or hallucinated citations in legal briefs, focusing on the recent federal…
Read More →
In Metacel Pharmaceuticals LLC v. Rubicon Research Private Ltd., the Court of Appeals for the Federal Circuit (CAFC) held that…
Read More →
The Health Resources and Services Administration (“HRSA”) plans to implement a limited pilot program that will allow approved manufacturers to…
Read More →
Recent reviews of genetic research continue to challenge long-held assumptions about the causes of malignant mesothelioma. While plaintiffs’ attorneys often…
Read More →
California’s Assembly Bill 489 (“AB 489”) signals more than just a tweak to existing healthcare law—it’s a glimpse into how…
Read More →